CATALYST BIOSCIENCES, INC. Equity Distribution Agreements

8 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Description of Gyre Therapeutics, Inc. Securities Registered Under Section 12 of the Exchange Act
Equity Distribution Agreements
CATALYST BIOSCIENCES, INC.
Biotechnology
2025
Open Market Sale Agreement between Gyre Therapeutics, Inc. and Jefferies LLC (November 27, 2024)
Equity Distribution Agreements
CATALYST BIOSCIENCES, INC.
Biotechnology
NY
2024
Description of Gyre Therapeutics, Inc. Securities Registered Under Section 12 of the Exchange Act
Equity Distribution Agreements
CATALYST BIOSCIENCES, INC.
Biotechnology
2024
Equity Distribution Agreement between Catalyst Biosciences, Inc. and Piper Sandler & Co. dated October 15, 2021
Equity Distribution Agreements
CATALYST BIOSCIENCES, INC.
Biotechnology
NY
2021
Description of Catalyst Biosciences, Inc. Securities Registered Under Section 12 of the Exchange Act
Equity Distribution Agreements
CATALYST BIOSCIENCES, INC.
Biotechnology
2020
At-the-Market Issuance Sales Agreement between Targacept, Inc. and MLV & Co. LLC (November 26, 2013)
Equity Distribution Agreements
CATALYST BIOSCIENCES, INC.
Biotechnology
NY
2013
Targacept, Inc. 2006 Stock Incentive Plan Restricted Stock Award Agreement
Equity Distribution Agreements
CATALYST BIOSCIENCES, INC.
Biotechnology
DE
2006
Targacept, Inc. Restricted Stock Award Agreement (Service-Based) under 2000 Equity Incentive Plan
Equity Distribution Agreements
CATALYST BIOSCIENCES, INC.
Biotechnology
DE
2006